help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mahata, S. K.
Right arrow Articles by O’Connor, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mahata, S. K.
Right arrow Articles by O’Connor, D. T.
Right arrowPubmed/NCBI databases
*Nucleotide
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Blood and Blood Disorders
Endocrinology Vol. 140, No. 2 739-749
Copyright © 1999 by The Endocrine Society


ARTICLES

Neuroendocrine Cell Type-Specific and Inducible Expression of the Secretogranin II Gene: Crucial Role of Cyclic Adenosine Monophosphate and Serum Response Elements1

Sushil K. Mahata, Manjula Mahata, Carolyn V. Livsey, Hans-Hermann Gerdes, Wieland B. Huttner and Daniel T. O’Connor

Department of Medicine and Center for Molecular Genetics (S.K.M., M.M., C.V.L., D.T.O’C.), University of California, and San Diego VA Healthcare System, San Diego, California 92161; and Department of Neurobiology, Heidelberg University (H.-H.G., W.B.H.), Heidelberg, Germany

Address all correspondence and requests for reprints to: Sushil K. Mahata, Ph.D., Department of Medicine and Center for Molecular Genetics (9111H), University of California, San Diego, 3350 La Jolla Village Drive, San Diego, California 92161-9111H. E-mail: smahata{at}ucsd.edu

Secretogranin II, an acidic protein in the chromogranin/secretogranin family, is widely distributed in neuroendocrine secretory granules. What factors govern such widespread, yet selective, expression? The 5' deletions localized neuroendocrine cell type-specific expression to the proximal mouse secretogranin II promoter: such expression was abolished after deletion past the cAMP response element (CRE; [-67 bp]TGACGTCA[-60 bp]), and transfer of the CRE to a neutral promoter conferred 3.4- to 5.3-fold neuroendocrine selectivity. Thus, the CRE is, at least partly, sufficient to confer tissue-specific expression. Substantial (48–59%) loss of cell type-specific expression also occurred upon deletion past the serum response element (SRE; [-302 bp]GATGTCC[-296 bp]), and transfer of the SRE to a neutral promoter also conferred neuroendocrine selectivity. Expression of both the endogenous gene and the transfected secretogranin II promoter was up-regulated after secretagogues, and the degree of trans-activation of the transfected promoter (2.2- to 5.4-fold) paralleled activation of the endogenous gene (1.8- to 3.2-fold). The 5' promoter deletions revealed complete loss of secretagogue responses after deletion past the CRE. Transfer of the CRE to a neutral promoter conferred secretagogue responses (by 2.2- to 18.6-fold). Substantial (59–74%) falls in secretagogue responses also occurred after deletion past the promoter’s SRE. Transfer of the SRE to a neutral promoter conferred secretagogue responses (by 2.7- to 8.3-fold). We conclude that the CRE is a crucial determinant of cell type-specific constitutive and secretagogue-inducible expression of the secretogranin II gene and that the SRE also plays a substantial role in both processes.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
N. R. Mahapatra, M. Mahata, D. T. O'Connor, and S. K. Mahata
Secretin Activation of Chromogranin A Gene Transcription: IDENTIFICATION OF THE SIGNALING PATHWAYS IN CIS AND IN TRANS
J. Biol. Chem., May 23, 2003; 278(22): 19986 - 19994.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
L. Taupenot, K. L. Harper, and D. T. O'Connor
The Chromogranin-Secretogranin Family
N. Engl. J. Med., March 20, 2003; 348(12): 1134 - 1149.
[Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
Y. Sakai, M. Hosaka, Y. Hira, T. Harumi, Y. Ohsawa, H. Wang, T. Takeuchi, Y. Uchiyama, and T. Watanabe
Immunocytochemical Localization of Secretogranin III in the Anterior Lobe of Male Rat Pituitary Glands
J. Histochem. Cytochem., February 1, 2003; 51(2): 227 - 238.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
V. Turquier, L. Yon, L. Grumolato, D. Alexandre, A. Fournier, H. Vaudry, and Y. Anouar
Pituitary Adenylate Cyclase-Activating Polypeptide Stimulates Secretoneurin Release and Secretogranin II Gene Transcription in Bovine Adrenochromaffin Cells through Multiple Signaling Pathways and Increased Binding of Pre-Existing Activator Protein-1-Like Transcription Factors
Mol. Pharmacol., July 1, 2001; 60(1): 42 - 52.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
N. R. Mahapatra, M. Mahata, A. K. Datta, H.-H. Gerdes, W. B. Huttner, D. T. O'Connor, and S. K. Mahata
Neuroendocrine Cell Type-Specific and Inducible Expression of the Chromogranin B Gene: Crucial Role of the Proximal Promoter
Endocrinology, October 1, 2000; 141(10): 3668 - 3678.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society